Table 2 Bacterial isolates and susceptibility characteristics to meropenem in clinically evaluable population

None cultured

10 (9.4%)

6 (5.6%)

0.310

n/a

n/a

n/a

Acinetobacter spp.

8 (7.5%)

12 (11.1%)

0.482

2.000 (1.000 to 2.000)

1.500 (1.500 to 2.000)

0.635

Citrobacter spp.

3 (2.8%)

4 (3.7%)

1.000

0.190 (0.092 to 0.422)

0.125 (0.040 to 0.470)

0.724

Enterobacter spp.

3 (2.8%)

7 (6.5%)

0.332

0.190 (0.093 to 0.331)

0.060 (0.053 to 0.090)

0.170

Escherichia coli

6 (5.7%)

9 (8.3%)

0.594

0.090 (0.090 to 0.120)

0.120 (0.072 to 0.380)

0.260

Klebsiella spp.

63 (59.4%)

50 (46.3%)

0.057

0.120 (0.090 to 0.130)

0.090 (0.060 to 0.130)

0.205

Morganella morganii

3 (2.8%)

5 (4.6%)

0.721

0.250 (0.250 to 0.542)

0.320 (0.250 to 0.535)

0.760

Pseudomonas aeruginosa

4 (3.8%)

6 (5.6%)

0.748

2.000 (1.750 to 2.000)

1.750 (1.000 to 2.000)

0.363

Serratia marcescens

4 (3.8%)

6 (5.6%)

0.748

0.110 (0.094 to 0.222)

0.125 (0.094 to 0.190)

0.830

Stenotrophomonas maltophilia

2 (1.9%)

3 (2.8%)

1,000

2.000 (2.000 to 2.000)

2.000 (1.625 to 2.000)

0.519

MIC of all microorganisms

0.125 (0.090 to 0.640)

0.130 (0.090 to 0,350)

0.970